Source: Virtual Congress 2020 – Exciting new developments in lung cancer screening, diagnostics and treatment



Rating:

Share or cite this content

Citations should be made in the following way:
S. Ocak (Yvoir, Belgium). Immunotherapy in SCLC: small step or leap?. Virtual Congress 2020 – Exciting new developments in lung cancer screening, diagnostics and treatment

Member's Comments

No comment yet.

Related content which might interest you: Immunotherapy: when, who and which drug? Source: International Congress 2018 – New drugs, strategies and research designs for advanced non-small cell lung cancer Year: 2018 Targeted therapies for lung cancer: how did the game begin? Source: Breathe 2016; 12: 177-179 Year: 2016 Lung cancer screening white paper: a slippery step forward? Source: Eur Respir J 2015; 46: 1519-1520 Year: 2015 Lung cancer screening white paper: a slippery step forward? Source: Eur Respir J 2015; 46: 1521-1522 Year: 2015 Immunotherapy for nonsmall cell lung cancer: a new therapeutic algorithm Source: Eur Respir J, 55 (2) 1901907; 10.1183/13993003.01907-2019 Year: 2020 Non-small cell lung cancer: how do experts want to be treated? Source: Virtual Congress 2021 – COVID-19 and management of lung cancer Year: 2021 ALK- and ROS-1-inhibition: a relevant treatment strategy for lung cancer? Source: International Congress 2014 – Update on lung cancer biology for clinicians Year: 2014 LATE-BREAKING ABSTRACT: Are small specimens" big enough" as therapeutic indicators in non-small cell lung cancer? Source: International Congress 2014 – New technologies and biomarkers in lung disease Year: 2014 Radiotherapy in small cell lung cancer: patient options Source: Virtual Congress 2020 – Thoracic oncology Year: 2020 Can we expect progress from targeted therapy of SCLC? Source: Eur Respir Monogr 2015; 68: 234-246 Year: 2015 Stem cells and lung cancer treatment: any hope? Source: International Congress 2016 – Molecular footprints in lung cancer diagnosis and management Year: 2016 Detection of operable lung cancer – a question of sheer luck? Source: Eur Respir J 2007; 30: Suppl. 51, 563s Year: 2007 Novel aspects in lung cancer pathology: how does it help for selecting chemotherapy? Source: Annual Congress 2010 - PG4 Core Curriculum Postgraduate Course: Pathology for the clinician Year: 2010 Lung cancer: keep your mind open – it's not always the usualsuspects! Source: Breathe, 16 (1) 190363; 10.1183/20734735.0363-2019 Year: 2020 Treatment of extensive-stage small cell lung carcinoma: current status and future prospects Source: Eur Respir J 2010; 35: 202-215 Year: 2010 Treating mesothelioma in 2021: what is the role of surgery and immunotherapy? Source: Virtual Congress 2021 – Hot news from the pleura Year: 2021